Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Outcomes with Real-World Use of Azacitidine and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Are Comparable to Long-Term Viale-a Results

Zalak Shah, Danielle Boselli, Stephanie Begley, Rupali Bose, Yifan Pang, Srinivasa Reddy Sanikommu, Nilay A. Shah, Aleksander L. Chojecki, Thomas G. Knight, Jing Ai, Belinda Avalos, Edward A. Copelan, Michael R. Grunwald, Brittany Knick Ragon

Blood (2024) 144 (Supplement 1): 5194.

https://doi.org/10.1182/blood-2024-201054

Published: 2024

Journal Articles

Neighborhood Disadvantage Is Associated with Inferior Overall Survival for Acute Myeloid Leukemia Patients Treated with Standard Intensive Induction

Brittany Knick Ragon, Danielle Boselli, Rupali Bose, Stephanie Begley, Melissa Aguiar, Kris Blackley, Nilay Shah, Aleksander L. Chojecki, Srinivasa Reddy Sanikommu, Yifan Pang, Jing Ai, Belinda Avalos, Edward A. Copelan, Thomas G. Knight, Michael R. Grunwald

Blood (2023) 142 (Supplement 1): 3799.

https://doi.org/10.1182/blood-2023-179352

Published: 2023

Journal Articles

MYC Pathway Upregulation Identified in Non-Responders to Hypomethylating Agents and Presents a Therapeutic Target in Acute Myeloid Leukemia

Brittany Knick Ragon, Margaret D. Templeton, Sara L. Seegers, Jenny Chen, Hsih-Te Yang, Thomas G. Knight, Jing Ai, Edward A. Copelan, Belinda Avalos, Nury M. Steuerwald, Jian Jin, Gang Greg Wang, Steven I. Park, Jai N. Patel, Michael R. Grunwald, Lawrence J. Druhan

Blood (2023) 142 (Supplement 1): 5741.

https://doi.org/10.1182/blood-2023-179318

Published: 2023

Journal Articles

Incidence and Risk Factors Associated with Fatal Graft Vs Host Disease after Solid Organ Transplantation in United Network of Organ Transplant Database

Pavan Tenneti, Jiaxian He, Peter Lalli, Pranav Tenneti, Michael R. Grunwald, Edward A. Copelan, Belinda Avalos, Srinivasa Reddy R. Sanikommu

Blood (2021) 138 (Supplement 1): 4067.

https://doi.org/10.1182/blood-2021-154104

Published: 2021

Journal Articles

Acute Myeloid Leukemia Patients in Complete Remission with Positive Measurable Residual Disease Prior to Allogeneic Transplant Have Worse Outcomes, Similar to Active Disease Regardless of Conditioning Regimen Intensity and Post-Transplant Cyclophosphamide Administration

Pavan Tenneti, Jiaxian He, Brittany Knick Ragon, Nilay A. Shah, Jing Ai, Aleksander L. Chojecki, Thomas G. Knight, Belinda Avalos, Edward A. Copelan, Michael R. Grunwald, Srinivasa Reddy R. Sanikommu

Blood (2021) 138 (Supplement 1): 4907.

https://doi.org/10.1182/blood-2021-154011

Published: 2021

Journal Articles

Aurora Kinase Inhibition Overcomes Primary Venetoclax Failure and Leads to Synthetic Lethality in BCL2-Positive Lymphomas Via Upregulation of P53/P21/BAX Axis

Rajeswaran Mani, Samon Benrashid, Sarah E Teague, Scott C Jaros, Hsih-Te Yang, Lawrence J Druhan, David M Foureau, Nury M Steuerwald, Nilanjan Ghosh, Edward A. Copelan, Donald L. Durden, Belinda Avalos, Steven I. Park

Blood (2021) 138 (Supplement 1): 682.

https://doi.org/10.1182/blood-2021-146064

Published: 2021

Journal Articles

Hereditary Chronic Neutrophilic Leukemia in a Four Generation Family without Transformation to Acute Leukemia

Zane Chiad, Amanda Lance, Sara L. Seegers, Sarah-Catherine Paschall, Kendra Drummond, Nury M Steuerwald, Peter M. Voorhees, Belinda Avalos, Lawrence J Druhan

Blood (2021) 138 (Supplement 1): 3594.

https://doi.org/10.1182/blood-2021-153899

Published: 2021

Journal Articles

Very Few Interventions after Tumor Lysis Monitoring in Patients with Chronic Lymphocytic Leukemia Who Are Started on Venetoclax in the Real-World Setting- Suggests Less Intensive Monitoring Maybe Safe for Low-Risk Patients

Ashley Matuszfisher, Rupali Bose, Danielle Boselli, Gray Magee, Tommy Chen, Bei Hu, Tamara K. Moyo, Amy Soni, Steven I. Park, Edward A. Copelan, Belinda Avalos, James T Symanowski, Derek Raghavan, Ryan Jacobs, Nilanjan Ghosh

Blood (2021) 138 (Supplement 1): 1557.

https://doi.org/10.1182/blood-2021-145714

Published: 2021

Journal Articles

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI

Blood (2013) 122 (24): 3863–3870.

https://doi.org/10.1182/blood-2013-07-514448

Published: 2013

Journal Articles

Lower Transplant-Related Mortality and Improved Survival for Patients with AML in First CR Receiving BuCy Compared to Cy/TBI As Myeloablative Preparation for Allogeneic Transplantation: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Edward A. Copelan, MD, Betty K. Hamilton, MD, Kwang W Ahn, PhD, Xiaochun Zhu, MS, Belinda Avalos, MD, Brian J. Bolwell, MD, Robert Peter Gale, MD, PhD, DSc, Jorge E. Cortes, MD, Matt Kalaycio, MD, Richard T. Maziarz, MD, Wael Saber, MD, MS

Blood (2012) 120 (21): 217.

https://doi.org/10.1182/blood.V120.21.217.217

Published: 2012

Journal Articles

Etoposide Priming in Patients with Lymphoma Improves Mobilization without An Increased Risk of Secondary Hematologic Malignancies.

Anuj Mahindra, MD, Brian J. Bolwell, Robert Dean, Matt Kalaycio, Belinda Avalos, Lisa Rybicki, Shawnda Tench, Patrick Elder, Ronald Sobecks, John Sweetenham, Brad Pohlman, Steve Andresen, Steve Devine, Edward Copelan

Blood (2009) 114 (22): 2264.

https://doi.org/10.1182/blood.V114.22.2264.2264

Published: 2009

Journal Articles

Incidence of Late Failure Following Myeloablative Conditioning with BuCy2 and Matched Sibling Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia.

Shubham Pant, M.D., Sayed Mehdi Hamadani, MD, Pamela Crilley, DO, Jeffrey Szer, Anthony J. Dodds, FRACP, FRCPA, Dustin E. Stevenson, DO, Gary Phillips, Patrick Elder, Ian Nivison-Smith, Belinda Avalos, Sam Penza, David Topolsky, R. Sobecks, Matt Kalaycio, MD, Brian J. Bolwell, MD, Edward Copelan

Blood (2008) 112 (11): 2172.

https://doi.org/10.1182/blood.V112.11.2172.2172

Published: 2008

Journal Articles

Late Mortality and Relapse Following HLA-Identical Sibling Donor Marrow Transplantation for Chronic Myeloid Leukemia.

Edward Copelan, Pamela Crilley, DO, Jeffrey Szer, Anthony J. Dodds, FRACP, FRCPA, Dustin E. Stevenson, DO, Gary Phillips, Patrick Elder, Ian Nivison-Smith, Belinda Avalos, Sam Penza, David Topolsky, R. Sobecks, Matt Kalaycio, Brian J. Bolwell, MD

Blood (2008) 112 (11): 3264.

https://doi.org/10.1182/blood.V112.11.3264.3264

Published: 2008

Journal Articles

Incidence of Extramedullary Relapse of Acute Myeloid Leukemia Following Transplantation with Busulfan-Based Conditioning Regimens.

William Blum, M.D., Sam Penza, M.D., Sherif Farag, M.D., Belinda Avalos, M.D., Guido Marcucci, M.D., Thomas Lin, M.D., John C. Byrd, M.D., Patrick Elder, Edward A. Copelan, M.D.

Blood (2004) 104 (11): 5123.

https://doi.org/10.1182/blood.V104.11.5123.5123

Published: 2004

Journal Articles

Single Institution Experience with Two High-Dose Chemotherapy (HDC) Conditioning Regimens Prior to Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM).

Don M. Benson, Patrick J. Elder, Thomas Lin, William Blum, Sam Penza, Belinda Avalos, John C. Byrd, Edward Copelan, Sherif S. Farag

Blood (2004) 104 (11): 5214.

https://doi.org/10.1182/blood.V104.11.5214.5214

Published: 2004

Journal Articles

Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation

Blood (1998) 92 (7): 2303–2314.

https://doi.org/10.1182/blood.V92.7.2303

Published: 1998

NARROW

Outcomes with Real-World Use of Azacitidine and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Are Comparable to Long-Term Viale-a Results

Neighborhood Disadvantage Is Associated with Inferior Overall Survival for Acute Myeloid Leukemia Patients Treated with Standard Intensive Induction

MYC Pathway Upregulation Identified in Non-Responders to Hypomethylating Agents and Presents a Therapeutic Target in Acute Myeloid Leukemia

Incidence and Risk Factors Associated with Fatal Graft Vs Host Disease after Solid Organ Transplantation in United Network of Organ Transplant Database

Acute Myeloid Leukemia Patients in Complete Remission with Positive Measurable Residual Disease Prior to Allogeneic Transplant Have Worse Outcomes, Similar to Active Disease Regardless of Conditioning Regimen Intensity and Post-Transplant Cyclophosphamide Administration

Aurora Kinase Inhibition Overcomes Primary Venetoclax Failure and Leads to Synthetic Lethality in BCL2-Positive Lymphomas Via Upregulation of P53/P21/BAX Axis

Hereditary Chronic Neutrophilic Leukemia in a Four Generation Family without Transformation to Acute Leukemia

Very Few Interventions after Tumor Lysis Monitoring in Patients with Chronic Lymphocytic Leukemia Who Are Started on Venetoclax in the Real-World Setting- Suggests Less Intensive Monitoring Maybe Safe for Low-Risk Patients

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI

Lower Transplant-Related Mortality and Improved Survival for Patients with AML in First CR Receiving BuCy Compared to Cy/TBI As Myeloablative Preparation for Allogeneic Transplantation: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Etoposide Priming in Patients with Lymphoma Improves Mobilization without An Increased Risk of Secondary Hematologic Malignancies.

Incidence of Late Failure Following Myeloablative Conditioning with BuCy2 and Matched Sibling Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia.

Late Mortality and Relapse Following HLA-Identical Sibling Donor Marrow Transplantation for Chronic Myeloid Leukemia.

Incidence of Extramedullary Relapse of Acute Myeloid Leukemia Following Transplantation with Busulfan-Based Conditioning Regimens.

Single Institution Experience with Two High-Dose Chemotherapy (HDC) Conditioning Regimens Prior to Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM).

Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only